Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Multiple Sclerosis

  Free Subscription


26.12.2022

2 J Neurol Neurosurg Psychiatry
1 J Neurol Sci
2 PLoS One
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    J Neurol Neurosurg Psychiatry

  1. SMITH KA, Piehl F, Olsson T, Alfredsson L, et al
    Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort study.
    J Neurol Neurosurg Psychiatry. 2022 Dec 20:jnnp-2022-329886.
    PubMed         Abstract available

  2. SIGNORI A, Lorscheider J, Vukusic S, Trojano M, et al
    Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
    J Neurol Neurosurg Psychiatry. 2023;94:23-30.
    PubMed         Abstract available


    J Neurol Sci

  3. XIAN C, Barbi C, Goldsworthy MR, Venturelli M, et al
    The interaction between metaplastic neuromodulation and fatigue in multiple sclerosis.
    J Neurol Sci. 2022;444:120521.
    PubMed         Abstract available


    PLoS One

  4. WOCHATZ M, Schraplau A, Engel T, Zecher MM, et al
    Application of eccentric training in various clinical populations: Protocol for a multi-centered pilot and feasibility study in people with low back pain and people with multiple sclerosis.
    PLoS One. 2022;17:e0270875.
    PubMed         Abstract available

  5. BEECHAM AH, Amezcua L, Chinea A, Manrique CP, et al
    Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population.
    PLoS One. 2022;17:e0279132.
    PubMed         Abstract available


    Rev Neurol

  6. SANCHEZ-VELASCO S, Midaglia L, Vidal-Jordana A, Castillo F, et al
    [Esclerosis multiple. Lactancia. Lactante. Planificacion familiar. Posparto. Tratamiento modificador de la enfermedad.].
    Rev Neurol. 2023;76:21-30.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: